CD226 and rheumatoid arthritis: Although stable remission was associated with expansion in the overall proportions of CD8+CD57+ NK cells, CD226 MFI was consistent across the spectrum of RA disease activity (Figure 3E), suggesting that changes in functional capacity are controlled through compositional shifts in the proportion of subsets expressing CD226 rather than changes in the expression at a subset level.